GI CONNECT has summarised the highlights of the ASCO GI 2015 meeting in San Francisco for you.
Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract by Dr Winder
Oncology
GI CONNECT Update from ASCO GI 2015
Episode 1: Pancreas, small bowel and hepatobiliary tract
Publication Date
Jun 2015
Dr Thomas Winder is board certified for haematology and medical oncology. Since January 2020 he has been Head of the Department for Haematology and Oncology at the University Teaching Hospital Feldkirch, Austria. In addition, since 2017 he has been President of the Swiss Tumor Molecular Institute in Zürich Switzerland. Dr Winder’s research focuses on molecular markers to individualize medical treatment of cancer patients. He achieved his expertise in internationally renowned laboratories at University of Southern California, Norris Comprehensive Cancer Center, Los Angeles and University Hospital Zürich, Switzerland. His research activity has been honoured by several national and international awards and high impact publications.
Download the slides 
Programme summary
Duration 5 MIN- Downloadable resources Yes
-
Download the slides
- Language(s)
Duration 
Language(s) 
Other episodes in this series
GI CONNECT Update from ASCO GI 2015
Episode 1: Pancreas, small bowel and hepatobiliary tract
Current Episode
Episode 2: Upper GI cancer
Episode 3: Lower GI cancer
Share this programme
Brought to you by
GI CONNECT is an initiative of COR2ED, supported by Independent Medical Educational Grants from Bayer and BeiGene Europe.
Meet the expertsOther programmes of interest
Video
Oncology
Celebrating the 10th anniversary of GI CONNECT
10 years of independent medical education in GI oncology
Experts
Assoc. Prof. Gerald Prager, Assoc. Prof. Joleen Hubbard, Dr Thomas Winder, Prof. Andrea Sartore-Bianchi, Dr Dominik Modest-
2 MIN
-
Apr 2024
2 MIN
Apr 2024
Tweetorial
Oncology
Tweetorial video: Treating ER+/HER2-low metastatic breast cancer, 2L and beyond
Journey through a patient case from testing and diagnosis to treatment and AE management
Experts
Dr Aditya BardiaEndorsed by
-
11 MIN
-
Apr 2024
Podcast
Oncology
Perseverance in molecular testing in NSCLC pays off
Looking beyond the obvious mutations in non-small-cell lung cancer
Experts
Prof. Frédérique Penault-Llorca, Prof. Mark Socinski-
Downloadable
Resources -
26 MIN
-
Mar 2024
Downloadable 
Conference update
Oncology
ER+ advanced breast cancer: Highlights from EBCC-14 satellite symposium
Medical experts discuss current and upcoming treatment strategies to use after CDK4/6 inhibitors in patients with ER+/HER2- advanced breast cancer
Experts
Prof. Valentina Guarneri, Prof. Matteo Lambertini, Prof. Federico Rojo-
Downloadable
Resources -
6 MIN
-
Mar 2024
Podcast
Oncology
mCRC: Optimising patient outcomes with late-line treatment
Maximising outcomes for patients with advanced CRC
Experts
Assoc. Prof. Gerald Prager, Dr Victor Hugo Fonseca de JesusEndorsed by
-
Downloadable
Resources -
23 MIN
-
Mar 2024
Interactive patient case
Oncology
TRK fusion-positive lung cancer: Diagnosis and treatment
Make decisions for your patient at two key stages in their journey
Experts
Prof. Fernando López-Ríos, Prof. Mark Socinski-
60 MIN
-
Mar 2024
